Familial hypercholesterolemia [NEW TOPIC PAGE]

Main|Search|PHGKB



From PubMed Clinical Queries

PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas

---

• Search PubMed Clinical Queries for "Familial hypercholesterolemia" 

Results: 5 of 3096

• Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials.
  Cao YX, Li S, Liu HH, Li JJ.BMJ Open. 2018 Oct 4; 8(9):e022348. Epub 2018 Oct 4.
• Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation.
  Cicero AFG, Fogacci F, Bove M, Ventura F, Giovannini M, Borghi C.High Blood Press Cardiovasc Prev. 2018 Sep 18; . Epub 2018 Sep 18.
• Identifying Patients for Nonstatin Therapy.
  Robinson JG, Watson KE.Rev Cardiovasc Med. 2018; 19(S1):S1-S8.
• Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study.
  Kullo IJ, Bailey KR.J Pers Med. 2018 Aug 23; 8(3). Epub 2018 Aug 23.
• Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan.
  Teramoto T, Usami M, Takagi Y, Baccara-Dinet MT, ODYSSEY Japan Investigators..J Atheroscler Thromb. 2018 Aug 1; . Epub 2018 Aug 1.

See all (3096)

This column displays citations filtered to a specific clinical study category and scope. These search filters were developed by Haynes RB et al. See more filter information.

Systematic Reviews

Results: 5 of 218

• Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials.
  Cao YX, Li S, Liu HH, Li JJ.BMJ Open. 2018 Oct 4; 8(9):e022348. Epub 2018 Oct 4.
• How do the experiences and beliefs of adults and children with heterozygous familial hypercholesterolaemia influence their adherence to treatment? A systematic review of qualitative evidence protocol.
  Kinnear FJ, Perry R, Searle A, Hamilton-Shield JP, Lithander FE.Syst Rev. 2018 Aug 16; 7(1):120. Epub 2018 Aug 16.
• Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
  Crosland P, Maconachie R, Buckner S, McGuire H, Humphries SE, Qureshi N.Atherosclerosis. 2018 Aug; 275:80-87. Epub 2018 May 17.
• Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
  Akioyamen LE, Genest J, Shan SD, Inibhunu H, Chu A, Tu JV.J Psychosom Res. 2018 Jun; 109:32-43. Epub 2018 Mar 27.
• Treatment Preferences in Germany Differ Among Apheresis Patients with Severe Hypercholesterolemia.
  Mühlbacher AC, Sadler A, Dippel FW, Juhnke C.Pharmacoeconomics. 2018 Apr; 36(4):477-493.

See all (218)

This column displays citations for systematic reviews, meta-analyses, reviews of clinical trials, evidence-based medicine, consensus development conferences, and guidelines. See filter information or additional related sources.

Medical Genetics

Topic:AllDiagnosisDifferential DiagnosisClinical DescriptionManagementGenetic CounselingMolecular GeneticsGenetic Testing

Results: 5 of 3969

• The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
  Al-Rasadi K, Alhabib KF, Al-Allaf F, Al-Waili K, Al-Zakwani I, AlSarraf A, Almahmeed W, AlSayed N, Alghamdi M, Batais MA, et al.Curr Vasc Pharmacol. 2018 Oct 5; . Epub 2018 Oct 5.
• Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia.
  Alver M, Palover M, Saar A, Läll K, Zekavat SM, Tõnisson N, Leitsalu L, Reigo A, Nikopensius T, Ainla T, et al.Genet Med. 2018 Oct 1; . Epub 2018 Oct 1.
• Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
  Futema M, Bourbon M, Williams M, Humphries SE.Atherosclerosis. 2018 Oct; 277:457-463.
• Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
  Hsiung YC, Lin PC, Chen CS, Tung YC, Yang WS, Chen PL, Su TC.Atherosclerosis. 2018 Oct; 277:440-447.
• Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
  Alnouri F, Athar M, Al-Allaf FA, Abduljaleel Z, Taher MM, Bouazzaoui A, Al Ammari D, Karrar H, Albabtain M.Atherosclerosis. 2018 Oct; 277:425-433.

See all (3969)

This column displays citations pertaining to topics in medical genetics. See more filter information.